Literature DB >> 29435739

Multiparametric Magnetic Resonance Imaging in the Assessment of Pulmonary Hypertension: Initial Experience of a One-Stop Study.

Gisela M B Meyer1, Fernanda B Spilimbergo1, Stephan Altmayer2,3,4, Gabriel S Pacini5,6,7, Matheus Zanon2,3,4, Guilherme Watte8,4, Edson Marchiori9, Bruno Hochhegger2,3,4.   

Abstract

INTRODUCTION: Our goal was to assess the diagnostic performance of magnetic resonance imaging (MRI) as a single method to diagnose pulmonary hypertension (PH) compared to right heart catheterization (RHC), computed tomography (CT), and ventilation/perfusion (V/Q) scintigraphy.
METHODS: We identified 35 patients diagnosed with PH by RHC in our institution who have also undergone a CT, a scintigraphy, and an MRI within a month. All cases were discussed in multidisciplinary meetings. We performed correlations between the MRI-derived hemodynamic parameters and those from RHC. The sensitivity and specificity of MRI were determined to identify its diagnostic performance to identify chronic thromboembolic pulmonary hypertension (CTEPH) and interstitial lung disease PH. The gold standard reference for the diagnosis of CTEPH and ILD was based on a review of multimodality imaging (V/Q scintigraphy and CT scan) and clinical findings.
RESULTS: Our results showed a good correlation between the hemodynamic parameters of cardiac MRI and RHC. Pulmonary vascular resistance had the best correlation between both methods (r = 0.923). The sensitivity and specificity of MRI to diagnose CTEPH was 100 and 96.8%, respectively. For the ILD-related PH, the MRI yielded a sensitivity of 60.0% and a specificity of 100%. Additionally, cardiac MRI was able to confirm all cases of PAH due to congenital heart disease initially detected by echocardiography.
CONCLUSIONS: MRI represents a promising imaging modality as an initial, single-shot study, for patients with suspected PH with the advantages of being non-invasive and having no radiation exposure.

Entities:  

Keywords:  Computed tomography; Lung scintigraphy; Magnetic resonance imaging; Pulmonary hypertension; Right heath catheterization

Mesh:

Year:  2018        PMID: 29435739     DOI: 10.1007/s00408-018-0097-7

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  25 in total

Review 1.  Magnetic resonance of the lung: a step forward in the study of lung disease.

Authors:  Bruno Hochhegger; Edson Marchiori; Klaus Irion; Arthur Soares Souza; Jackson Volkart; Adalberto S Rubin
Journal:  J Bras Pneumol       Date:  2012 Jan-Feb       Impact factor: 2.624

2.  Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.

Authors:  David Launay; Luc Mouthon; Eric Hachulla; Christian Pagnoux; Pascal de Groote; Martine Remy-Jardin; Regis Matran; Marc Lambert; Viviane Queyrel; Sandrine Morell-Dubois; Loic Guillevin; Pierre-Yves Hatron
Journal:  J Rheumatol       Date:  2007-04-15       Impact factor: 4.666

3.  ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre.

Authors:  J Hurdman; R Condliffe; C A Elliot; C Davies; C Hill; J M Wild; D Capener; P Sephton; N Hamilton; I J Armstrong; C Billings; A Lawrie; I Sabroe; M Akil; L O'Toole; D G Kiely
Journal:  Eur Respir J       Date:  2011-09-01       Impact factor: 16.671

Review 4.  Magnetic resonance imaging findings in acute pulmonary embolism.

Authors:  B Hochhegger; J Ley-Zaporozhan; E Marchiori; K Irion; A Soares Souza; J Moreira; H U Kauczor; S Ley
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

5.  Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial.

Authors:  Michael J Kovacs; Marc Rodger; David R Anderson; Beverly Morrow; Gertrude Kells; Judy Kovacs; Eleanor Boyle; Philip S Wells
Journal:  Ann Intern Med       Date:  2003-05-06       Impact factor: 25.391

Review 6.  The emerging role of magnetic resonance imaging in the diagnosis and management of pulmonary hypertension.

Authors:  Gabor Kovacs; Gert Reiter; Ursula Reiter; Rainer Rienmüller; Andrew Peacock; Horst Olschewski
Journal:  Respiration       Date:  2008-11-12       Impact factor: 3.580

7.  User-initialized active contour segmentation and golden-angle real-time cardiovascular magnetic resonance enable accurate assessment of LV function in patients with sinus rhythm and arrhythmias.

Authors:  Francisco Contijoch; Walter R T Witschey; Kelly Rogers; Hannah Rears; Michael Hansen; Paul Yushkevich; Joseph Gorman; Robert C Gorman; Yuchi Han
Journal:  J Cardiovasc Magn Reson       Date:  2015-05-21       Impact factor: 5.364

Review 8.  Quantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the art.

Authors:  Andrew J Swift; Jim M Wild; Scott K Nagle; Alejandro Roldán-Alzate; Christopher J François; Sean Fain; Kevin Johnson; Dave Capener; Edwin J R van Beek; David G Kiely; Kang Wang; Mark L Schiebler
Journal:  J Thorac Imaging       Date:  2014-03       Impact factor: 3.000

9.  Lung perfusion: MRI vs. SPECT for screening in suspected chronic thromboembolic pulmonary hypertension.

Authors:  Christopher S Johns; Andrew J Swift; Smitha Rajaram; Paul J C Hughes; David J Capener; David G Kiely; James M Wild
Journal:  J Magn Reson Imaging       Date:  2017-04-04       Impact factor: 4.813

10.  Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry.

Authors:  Andrew J Swift; Smitha Rajaram; Judith Hurdman; Catherine Hill; Christine Davies; Tom W Sproson; Allison C Morton; Dave Capener; Charlie Elliot; Robin Condliffe; Jim M Wild; David G Kiely
Journal:  JACC Cardiovasc Imaging       Date:  2013-06-13
View more
  1 in total

Review 1.  Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension: Ready for Clinical Practice and Guidelines?

Authors:  Barbro Kjellström; Anthony Lindholm; Ellen Ostenfeld
Journal:  Curr Heart Fail Rep       Date:  2020-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.